{"altmetric_id":4884418,"counts":{"readers":{"mendeley":15,"citeulike":0,"connotea":0},"total":{"posts_count":22},"twitter":{"unique_users_count":16,"unique_users":["BibCCBSUFCG","epigen_papers","GenomeMedicine","dirk_paul","garrymyers","CancerMedMDA","wearecare","Manojkumar008","blueprint_eu","laurastephen","EpigenomicMed","IHEC_Epigenomes","uclcancer","EpiGeneSysFP7","SzoradovaS","introspection"],"posts_count":22}},"selected_quotes":["An epigenetic biomarker to predict graft-versus-host disease. Paper here: @GenomeMedicine @uclcancer\u2026","Epigenetic classifier for acute graft-versus-host disease severity in hematopoietic stem cell transplantation","A donor-specific epigenetic classifier for acute graft-versus-host disease severity in hematopoietic (...)","U.K. researchers discover 31 DNA methylation marks in donors associated with GVHD severity status in HSC recipients"],"citation":{"abstract":"Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative treatment for many hematological conditions. Acute graft-versus-host disease (aGVHD) is a prevalent immune-mediated complication following HSCT. Current diagnostic biomarkers that correlate with aGVHD severity, progression, and therapy response in graft recipients are insufficient. Here, we investigated whether epigenetic marks measured in peripheral blood of healthy graft donors stratify aGVHD severity in human leukocyte antigen (HLA)-matched sibling recipients prior to T cell-depleted HSCT.\nWe measured DNA methylation levels genome-wide at single-nucleotide resolution in peripheral blood of 85 HSCT donors, matched to recipients with various transplant outcomes, with Illumina Infinium HumanMethylation450 BeadChips.\nUsing genome-wide DNA methylation profiling, we showed that epigenetic signatures underlying aGVHD severity in recipients correspond to immune pathways relevant to aGVHD etiology. We discovered 31 DNA methylation marks in donors that associated with aGVHD severity status in recipients, and demonstrated strong predictive performance of these markers in internal cross-validation experiments (AUC\u2009=\u20090.98, 95\u00a0% CI\u2009=\u20090.96-0.99). We replicated the top-ranked CpG classifier using an alternative, clinical DNA methylation assay (P\u2009=\u20090.039). In an independent cohort of 32 HSCT donors, we demonstrated the utility of the epigenetic classifier in the context of a T cell-replete conditioning regimen (P\u2009=\u20090.050).\nOur findings suggest that epigenetic typing of HSCT donors in a clinical setting may be used in conjunction with HLA genotyping to inform both donor selection and transplantation strategy, with the ultimate aim of improving patient outcome.","altmetric_jid":"4f6fa4d03cf058f610000823","authors":["Dirk S Paul","Allison Jones","Rob S Sellar","Neema P Mayor","Andrew Feber","Amy P Webster","Neuza Afonso","Ruhena Sergeant","Richard M Szydlo","Jane F Apperley","Martin Widschwendter","Stephen Mackinnon","Steven GE Marsh","J. A Madrigal","Vardhman K Rakyan","Karl S Peggs","Stephan Beck","Paul, Dirk S","Jones, Allison","Sellar, Rob S","Mayor, Neema P","Feber, Andrew","Webster, Amy P","Afonso, Neuza","Sergeant, Ruhena","Szydlo, Richard M","Apperley, Jane F","Widschwendter, Martin","Mackinnon, Stephen","Marsh, Steven G E","Madrigal, J Alejandro","Rakyan, Vardhman K","Peggs, Karl S","Beck, Stephan","Dirk S. Paul","Rob S. Sellar","Neema P. Mayor","Amy P. Webster","Richard M. Szydlo","Jane F. Apperley","Steven G. E. Marsh","J. Alejandro Madrigal","Vardhman K. Rakyan","Karl S. Peggs"],"doi":"10.1186\/s13073-015-0246-z","first_seen_on":"2015-12-16T15:45:28+00:00","funders":["niehs","wellcome","dohuk","cruk","mrc","bhf"],"issns":["1756-994X"],"issue":"1","journal":"Genome Medicine","last_mentioned_on":1459949650,"links":["http:\/\/www.genomemedicine.com\/content\/7\/1\/128?utm_source=dlvr.it&utm_medium=twitter","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26669438?dopt=Abstract&utm_source=dlvr.it&utm_medium=twitter","http:\/\/www.genomemedicine.com\/content\/7\/1\/128","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=26669438","https:\/\/genomemedicine.biomedcentral.com\/articles\/10.1186\/s13073-015-0246-z"],"pdf_url":"http:\/\/genomemedicine.com\/content\/pdf\/s13073-015-0246-z.pdf","pmcid":"PMC4681168","pmid":"26669438","pubdate":"2015-12-15T00:00:00+00:00","publisher":"BioMed Central Ltd","publisher_subjects":[{"name":"Bioinformatics","scheme":"springer"},{"name":"Biomedicine","scheme":"springer"},{"name":"Human Genetics","scheme":"springer"},{"name":"Internal Medicine","scheme":"springer"},{"name":"Proteomics","scheme":"springer"},{"name":"Genetics","scheme":"era"},{"name":"Clinical Sciences","scheme":"era"}],"startpage":"128","title":"A donor-specific epigenetic classifier for acute graft-versus-host disease severity in hematopoietic stem cell transplantation.","type":"article","uri":"http:\/\/genomemedicine.com\/content\/7\/1\/128","volume":"7","mendeley_url":"http:\/\/www.mendeley.com\/research\/donorspecific-epigenetic-classifier-acute-graftversushost-disease-severity-hematopoietic-stem-cell-t-2"},"altmetric_score":{"score":9.25,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":9.25},"context_for_score":{"all":{"total_number_of_other_articles":7506617,"mean":6.4985319251666,"rank":787404,"this_scored_higher_than_pct":89,"this_scored_higher_than":6709093,"rank_type":"exact","sample_size":7506617,"percentile":89},"similar_age_3m":{"total_number_of_other_articles":297120,"mean":8.8713330820309,"rank":42159,"this_scored_higher_than_pct":85,"this_scored_higher_than":254215,"rank_type":"exact","sample_size":297120,"percentile":85},"this_journal":{"total_number_of_other_articles":671,"mean":19.274241791045,"rank":277,"this_scored_higher_than_pct":58,"this_scored_higher_than":393,"rank_type":"exact","sample_size":671,"percentile":58},"similar_age_this_journal_3m":{"total_number_of_other_articles":32,"mean":19.954451612903,"rank":15,"this_scored_higher_than_pct":53,"this_scored_higher_than":17,"rank_type":"exact","sample_size":32,"percentile":53}}},"demographics":{"poster_types":{"member_of_the_public":9,"researcher":4,"practitioner":2,"science_communicator":1},"users":{"twitter":{"cohorts":{"Members of the public":11,"Science communicators (journalists, bloggers, editors)":1,"Scientists":3,"Practitioners (doctors, other healthcare professionals)":1}},"mendeley":{"by_status":{"Professor > Associate Professor":1,"Researcher":5,"Student  > Ph. D. Student":4,"Other":3,"Student  > Master":1,"Professor":1},"by_discipline":{"Medicine and Dentistry":5,"Agricultural and Biological Sciences":4,"Biochemistry, Genetics and Molecular Biology":4,"Unspecified":2}}},"geo":{"twitter":{"FR":2,"GB":5,"AU":1,"US":1,"CA":1,"SK":1},"mendeley":{"US":1,"GB":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/BibCCBSUFCG\/statuses\/677152466572476416","license":"gnip","citation_ids":[4884418],"posted_on":"2015-12-16T15:45:03+00:00","author":{"name":"Biblioteca CCBS-UFCG","url":"http:\/\/bibliotecaccbs.strikingly.com","image":"https:\/\/pbs.twimg.com\/profile_images\/482133107114397696\/8xBpB52X_normal.jpeg","id_on_source":"BibCCBSUFCG","tweeter_id":"2458056060","geo":{"lt":null,"ln":null},"followers":14},"tweet_id":"677152466572476416"},{"url":"http:\/\/twitter.com\/epigen_papers\/statuses\/677494222677655553","license":"gnip","citation_ids":[4884418],"posted_on":"2015-12-17T14:23:04+00:00","author":{"name":"epigenetics_papers","url":"http:\/\/en.wikipedia.org\/wiki\/Epigenetics","image":"https:\/\/pbs.twimg.com\/profile_images\/471205704921931776\/wSQqKYz8_normal.jpeg","description":"Chromatin & epigenetics paper feed from #Pubmed and #Arxiv - hear it here first! Comments & suggestions welcome. Also http:\/\/t.co\/0Lque7l3ZD By @mariamdemidova","id_on_source":"epigen_papers","tweeter_id":"2526900595","geo":{"lt":48.11198,"ln":-1.67429,"country":"FR"},"followers":1919},"tweet_id":"677494222677655553"},{"url":"http:\/\/twitter.com\/GenomeMedicine\/statuses\/677531043562455045","license":"gnip","citation_ids":[4884418],"posted_on":"2015-12-17T16:49:23+00:00","author":{"name":"Genome Medicine","url":"http:\/\/genomemedicine.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/677485286901866496\/4sPlbcXR_normal.png","description":"Genome Medicine is an Open Access @BioMedCentral journal covering all areas of medicine studied from a post-genomic perspective. Sister to @GenomeBiology","id_on_source":"GenomeMedicine","tweeter_id":"127910801","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":17564},"tweet_id":"677531043562455045"},{"url":"http:\/\/twitter.com\/dirk_paul\/statuses\/677534354151751681","license":"gnip","rt":["GenomeMedicine"],"citation_ids":[4884418],"posted_on":"2015-12-17T17:02:32+00:00","author":{"name":"Dirk Paul","url":"http:\/\/www.phpc.cam.ac.uk\/ceu\/genomics\/","image":"https:\/\/pbs.twimg.com\/profile_images\/550990210935185408\/UX8QbHBQ_normal.jpeg","description":"Lecturer & Team Leader in Integrative Human Genomics at the University of Cambridge. Part-time hipster.","id_on_source":"dirk_paul","tweeter_id":"401396906","geo":{"lt":52.2,"ln":0.11667,"country":"GB"},"followers":131},"tweet_id":"677534354151751681"},{"url":"http:\/\/twitter.com\/dirk_paul\/statuses\/677536465128194050","license":"gnip","citation_ids":[4884418],"posted_on":"2015-12-17T17:10:55+00:00","author":{"name":"Dirk Paul","url":"http:\/\/www.phpc.cam.ac.uk\/ceu\/genomics\/","image":"https:\/\/pbs.twimg.com\/profile_images\/550990210935185408\/UX8QbHBQ_normal.jpeg","description":"Lecturer & Team Leader in Integrative Human Genomics at the University of Cambridge. Part-time hipster.","id_on_source":"dirk_paul","tweeter_id":"401396906","geo":{"lt":52.2,"ln":0.11667,"country":"GB"},"followers":131},"tweet_id":"677536465128194050"},{"url":"http:\/\/twitter.com\/GenomeMedicine\/statuses\/677539823813455872","license":"gnip","rt":["dirk_paul"],"citation_ids":[4884418],"posted_on":"2015-12-17T17:24:16+00:00","author":{"name":"Genome Medicine","url":"http:\/\/genomemedicine.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/677485286901866496\/4sPlbcXR_normal.png","description":"Genome Medicine is an Open Access @BioMedCentral journal covering all areas of medicine studied from a post-genomic perspective. Sister to @GenomeBiology","id_on_source":"GenomeMedicine","tweeter_id":"127910801","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":17564},"tweet_id":"677539823813455872"},{"url":"http:\/\/twitter.com\/garrymyers\/statuses\/677544290717859840","license":"gnip","rt":["dirk_paul"],"citation_ids":[4884418],"posted_on":"2015-12-17T17:42:01+00:00","author":{"name":"Garry Myers","url":"https:\/\/www.uts.edu.au\/staff\/garry.myers","image":"https:\/\/pbs.twimg.com\/profile_images\/542561143231754240\/mRyP0i3A_normal.png","description":"Assoc. Prof. & Group Leader | Program Director BAdvSci (Infection & Immunity) | #chlamydia #hostpathogen #bioinformatics #systemsbiology","id_on_source":"garrymyers","tweeter_id":"1377801","geo":{"lt":-33.86785,"ln":151.20732,"country":"AU"},"followers":445},"tweet_id":"677544290717859840"},{"url":"http:\/\/twitter.com\/CancerMedMDA\/statuses\/677547956262731776","license":"gnip","citation_ids":[4884418],"posted_on":"2015-12-17T17:56:35+00:00","author":{"name":"Cancer Medicine","url":"http:\/\/www.mdanderson.org\/cancermedicine","image":"https:\/\/pbs.twimg.com\/profile_images\/876836086554677249\/pl7C_g0f_normal.jpg","description":"Mission of largest MD Anderson division is to eliminate cancer via best, integrated patient care, research & education programs. Appts.available 877-632-6789.","id_on_source":"CancerMedMDA","tweeter_id":"851503992","geo":{"lt":29.76328,"ln":-95.36327,"country":"US"},"followers":3401},"tweet_id":"677547956262731776"},{"url":"http:\/\/twitter.com\/wearecare\/statuses\/677549513591103489","license":"gnip","rt":["CancerMedMDA"],"citation_ids":[4884418],"posted_on":"2015-12-17T18:02:46+00:00","author":{"name":"CARE Education","url":"http:\/\/www.careeducation.ca","image":"https:\/\/pbs.twimg.com\/profile_images\/3189150342\/b7675358fee227ae343c902d6d92f6be_normal.png","description":"CARE is dedicated to providing relevant Canadian #medical & #health care news\/education in various therapeutic areas to residents, fellows, specialists & aHCPs","id_on_source":"wearecare","tweeter_id":"1109742336","geo":{"lt":43.70011,"ln":-79.4163,"country":"CA"},"followers":1955},"tweet_id":"677549513591103489"},{"url":"http:\/\/twitter.com\/Manojkumar008\/statuses\/677554296255201281","license":"gnip","rt":["dirk_paul"],"citation_ids":[4884418],"posted_on":"2015-12-17T18:21:47+00:00","author":{"name":"Manojkumar","image":"https:\/\/pbs.twimg.com\/profile_images\/639378961894473728\/O3mvnHNE_normal.jpg","id_on_source":"Manojkumar008","tweeter_id":"323086946","geo":{"lt":null,"ln":null},"followers":422},"tweet_id":"677554296255201281"},{"url":"http:\/\/twitter.com\/Manojkumar008\/statuses\/677558663733612544","license":"gnip","rt":["GenomeMedicine"],"citation_ids":[4884418],"posted_on":"2015-12-17T18:39:08+00:00","author":{"name":"Manojkumar","image":"https:\/\/pbs.twimg.com\/profile_images\/639378961894473728\/O3mvnHNE_normal.jpg","id_on_source":"Manojkumar008","tweeter_id":"323086946","geo":{"lt":null,"ln":null},"followers":422},"tweet_id":"677558663733612544"},{"url":"http:\/\/twitter.com\/blueprint_eu\/statuses\/677564657004126209","license":"gnip","rt":["dirk_paul"],"citation_ids":[4884418],"posted_on":"2015-12-17T19:02:57+00:00","author":{"name":"Blueprint","url":"http:\/\/www.blueprint-epigenome.eu","image":"https:\/\/pbs.twimg.com\/profile_images\/545907819715653632\/6OXLNxjO_normal.jpeg","description":"BLUEPRINT - a BLUEPRINT of Haematopoietic Epigenomes - is a large-scale FP7 research project receiving close to 30 million euro funding from the EU.","id_on_source":"blueprint_eu","tweeter_id":"1924615722","geo":{"lt":null,"ln":null},"followers":394},"tweet_id":"677564657004126209"},{"url":"http:\/\/twitter.com\/laurastephen\/statuses\/677564793453191168","license":"gnip","rt":["dirk_paul"],"citation_ids":[4884418],"posted_on":"2015-12-17T19:03:29+00:00","author":{"name":"laura clarke","image":"https:\/\/pbs.twimg.com\/profile_images\/1475968619\/profile_pic_normal.jpg","description":"Bioinformatics, Books and some random other musings","id_on_source":"laurastephen","tweeter_id":"20142273","geo":{"lt":52.2,"ln":0.11667,"country":"GB"},"followers":726},"tweet_id":"677564793453191168"},{"url":"http:\/\/twitter.com\/EpigenomicMed\/statuses\/677567674017296384","license":"gnip","rt":["GenomeMedicine"],"citation_ids":[4884418],"posted_on":"2015-12-17T19:14:56+00:00","author":{"name":"Epigenomic Medicine","image":"https:\/\/pbs.twimg.com\/profile_images\/461578103630741504\/wy75HsTS_normal.jpeg","description":"Research Group: PI Christopher G Bell","id_on_source":"EpigenomicMed","tweeter_id":"2471363677","geo":{"lt":54.75844,"ln":-2.69531,"country":"GB"},"followers":275},"tweet_id":"677567674017296384"},{"url":"http:\/\/twitter.com\/IHEC_Epigenomes\/statuses\/679059268826300416","license":"gnip","rt":["dirk_paul"],"citation_ids":[4884418],"posted_on":"2015-12-21T22:02:00+00:00","author":{"name":"IHEC_Epigenomes","url":"http:\/\/ihec-epigenomes.org","image":"https:\/\/pbs.twimg.com\/profile_images\/591220377512189952\/ANrpYvKO_normal.png","description":"International Human Epigenome Consortium. IHEC & other #epigenomics \/ #epigenetics news, resources, jobs & events. Third-party content not necessarily endorsed.","id_on_source":"IHEC_Epigenomes","tweeter_id":"3197587503","geo":{"lt":null,"ln":null},"followers":1465},"tweet_id":"679059268826300416"},{"url":"http:\/\/twitter.com\/uclcancer\/statuses\/679069810173599744","license":"gnip","rt":["dirk_paul"],"citation_ids":[4884418],"posted_on":"2015-12-21T22:43:53+00:00","author":{"name":"uclcancer","url":"http:\/\/www.ucl.ac.uk\/cancer","image":"https:\/\/pbs.twimg.com\/profile_images\/798548624422617089\/e4HRE7mt_normal.jpg","description":"@ucl Cancer Institute: talented researchers \/ clinicians working to translate research discoveries into strategies to prevent, diagnose & treat cancer.","id_on_source":"uclcancer","tweeter_id":"87428607","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":842},"tweet_id":"679069810173599744"},{"url":"http:\/\/twitter.com\/EpiGeneSysFP7\/statuses\/679666023591751680","license":"gnip","citation_ids":[4884418],"posted_on":"2015-12-23T14:13:02+00:00","author":{"name":"EpiGeneSys.eu","url":"http:\/\/epigenesys.eu","image":"https:\/\/pbs.twimg.com\/profile_images\/507169736606482432\/120p8AmE_normal.png","description":"An FP7 European Community-funded Network of Excellence advancing research by drawing together epigenetics and systems biology researchers","id_on_source":"EpiGeneSysFP7","tweeter_id":"338920909","geo":{"lt":null,"ln":null},"followers":662},"tweet_id":"679666023591751680"},{"url":"http:\/\/twitter.com\/EpiGeneSysFP7\/statuses\/679691036705308672","license":"gnip","citation_ids":[4884418],"posted_on":"2015-12-23T15:52:25+00:00","author":{"name":"EpiGeneSys.eu","url":"http:\/\/epigenesys.eu","image":"https:\/\/pbs.twimg.com\/profile_images\/507169736606482432\/120p8AmE_normal.png","description":"An FP7 European Community-funded Network of Excellence advancing research by drawing together epigenetics and systems biology researchers","id_on_source":"EpiGeneSysFP7","tweeter_id":"338920909","geo":{"lt":null,"ln":null},"followers":662},"tweet_id":"679691036705308672"},{"url":"http:\/\/twitter.com\/dirk_paul\/statuses\/679695296968916993","license":"gnip","rt":["EpiGeneSysFP7"],"citation_ids":[4884418],"posted_on":"2015-12-23T16:09:21+00:00","author":{"name":"Dirk Paul","url":"http:\/\/www.phpc.cam.ac.uk\/ceu\/genomics\/","image":"https:\/\/pbs.twimg.com\/profile_images\/550990210935185408\/UX8QbHBQ_normal.jpeg","description":"Lecturer & Team Leader in Integrative Human Genomics at the University of Cambridge. Part-time hipster.","id_on_source":"dirk_paul","tweeter_id":"401396906","geo":{"lt":52.2,"ln":0.11667,"country":"GB"},"followers":131},"tweet_id":"679695296968916993"},{"url":"http:\/\/twitter.com\/IHEC_Epigenomes\/statuses\/682257540583915520","license":"gnip","citation_ids":[4884418],"posted_on":"2015-12-30T17:50:48+00:00","author":{"name":"IHEC_Epigenomes","url":"http:\/\/ihec-epigenomes.org","image":"https:\/\/pbs.twimg.com\/profile_images\/591220377512189952\/ANrpYvKO_normal.png","description":"International Human Epigenome Consortium. IHEC & other #epigenomics \/ #epigenetics news, resources, jobs & events. Third-party content not necessarily endorsed.","id_on_source":"IHEC_Epigenomes","tweeter_id":"3197587503","geo":{"lt":null,"ln":null},"followers":1465},"tweet_id":"682257540583915520"},{"url":"http:\/\/twitter.com\/SzoradovaS\/statuses\/688025320218333185","license":"gnip","rt":["GenomeMedicine"],"citation_ids":[4884418],"posted_on":"2016-01-15T15:49:53+00:00","author":{"name":"Sabina Szoradova","image":"https:\/\/pbs.twimg.com\/profile_images\/692651449692602368\/dqZuv2_0_normal.jpg","description":"medschool graduate","id_on_source":"SzoradovaS","tweeter_id":"2360672141","geo":{"lt":48.66667,"ln":19.5,"country":"SK"},"followers":75},"tweet_id":"688025320218333185"},{"url":"http:\/\/twitter.com\/introspection\/statuses\/717706967901474816","license":"gnip","citation_ids":[4884418],"posted_on":"2016-04-06T13:34:10+00:00","author":{"name":"Guillaume Dumas \u2623\ufe0f\ud83e\udd16","url":"http:\/\/www.extrospection.eu","image":"https:\/\/pbs.twimg.com\/profile_images\/681158719871258624\/s-nWU7Mb_normal.jpg","description":"\ud83d\udcf6 Multiscale Neurosci \ud83d\udd04 AI\/ML \u27a1\ufe0f SysBio\/CompPsychiatry (@InstitutPasteur faculty) \ud83c\udd93\u00a0Knowledge \u2194\ufe0f Commons \u27a1\ufe0f Opening Science (@HackYourPhD cofounder)","id_on_source":"introspection","tweeter_id":"14403154","geo":{"lt":48.85341,"ln":2.3488,"country":"FR"},"followers":3380},"tweet_id":"717706967901474816"}]}}